RxDoctor Payments Data

Stephanie Senft, PA

Physician Assistant · Palmyra, PANPI 1861984072

Payments from drug & device makers

$9,638in general payments, 2019–2025

Across 581 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • AstraZeneca$864
  • GSK$819
  • Lilly USA, LLC$499
  • Amgen$425
  • plus $4K from 40 others

What the payments were for

  • Food & beverage$9,626100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,638 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$31,011
Medicare patients
164
Services billed
582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin84$87,993
OzempicSemaglutide45$55,460
EliquisApixaban42$37,479
XareltoRivaroxaban19$20,405
FarxigaDapagliflozin Propanediol14$16,624
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$15,393
MyrbetriqMirabegron18$13,755
LinzessLinaclotide14$10,894
Breo ElliptaFluticasone/Vilanterol17$9,585
Fluticasone-SalmeterolFluticasone Propion/Salmeterol44$4,047
Atorvastatin Calcium214$2,671
Levothyroxine Sodium235$2,207
Lo Loestrin FeNorethindrone-E.Estradiol-Iron11$2,063
Omeprazole159$1,948
Fenofibrate12$1,757

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$127$87,99384 claims
Novo NordiskOzempic$1,072$55,46045 claims
PfizerEliquis$419$37,47942 claims
GSKTrelegy Ellipta, Breo Ellipta$819$24,97833 claims
Johnson & JohnsonXarelto$155$20,40519 claims
AstraZenecaFarxiga$864$16,62414 claims
AbbVieLinzess, Lo Loestrin Fe, Synthroid$1,953$14,35141 claims
Astellas Pharma US IncMyrbetriq$147$13,75518 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$29$2,207235 claims
Almatica Pharma LLCSertraline Hcl$29$1,455107 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Palmyra

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →